Mytrex Health Technologies, Inc. Statistics
Mytrex Health Technologies, Inc. (4431) Stock Statistics & Valuation Metrics
Total Valuation
Mytrex Health Technologies, Inc. has a market cap or net worth of TWD 868.07M. The enterprise value is ―.
- Market Cap
- TWD 868.07M
- Enterprise Value
- ―
Share Statistics
Mytrex Health Technologies, Inc. has 41,935,513 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 41,935,513
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Mytrex Health Technologies, Inc.’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -3.99%.
- Return on Equity (ROE)
- -0.03
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- -3.99%
- Return on Capital Employed (ROCE)
- -0.05
- Revenue Per Employee
- 38.90M
- Profits Per Employee
- -332.00K
- Employee Count
- 50
- Asset Turnover
- 1.64
- Inventory Turnover
- 8.19
Valuation Ratios
The current PE Ratio of Mytrex Health Technologies, Inc. is -148.93. Mytrex Health Technologies, Inc.’s PEG ratio is -0.73.
- PE Ratio
- -148.93
- PS Ratio
- 0.37
- PB Ratio
- 1.34
- Price to FCF
- 3.46
- Price to Operating Cash Flow
- 3.47
- PEG Ratio
- -0.73
Income Statement
In the last 12 months, Mytrex Health Technologies, Inc. had revenue of 1.94B and earned -16.60M in profits. Earnings per share was -0.45.
- Revenue
- 1.94B
- Gross Profit
- 218.77M
- Operating Income
- -30.63M
- Pretax Income
- -21.50M
- Net Income
- -16.60M
- EBITDA
- 7.17M
- Earnings Per Share (EPS)
- -0.45
Cash Flow
In the last 12 months, operating cash flow was 225.20M and capital expenditures -4.95M, giving a free cash flow of 220.25M billion.
- Operating Cash Flow
- 225.20M
- Free Cash Flow
- 220.25M
- Free Cash Flow per Share
- 5.88
Dividends & Yields
Mytrex Health Technologies, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 28.30%
- Earnings Yield
- -0.67%
Stock Price Statistics
- Beta
- 0.39
- 52-Week Price Change
- 16.62%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 50.36
- Average Volume (3m)
- 59.81K
Financial Position
Mytrex Health Technologies, Inc. as a current ratio of 1.58, with Debt / Equity ratio of 28.24%
- Current Ratio
- 1.58
- Quick Ratio
- 1.17
- Debt to Market Cap
- 0.15
- Net Debt to EBITDA
- -19.31
- Interest Coverage Ratio
- -6.02
Taxes
In the past 12 months, Mytrex Health Technologies, Inc. has paid 4.35M in taxes.
- Income Tax
- 4.35M
- Effective Tax Rate
- -0.20
Enterprise Valuation
Mytrex Health Technologies, Inc. EV to EBITDA ratio is 26.60, with an EV/FCF ratio of 2.76.
- EV to Sales
- 0.30
- EV to EBITDA
- 26.60
- EV to Free Cash Flow
- 2.76
- EV to Operating Cash Flow
- 2.70
Balance Sheet
Mytrex Health Technologies, Inc. has TWD 419.87M in cash and marketable securities with TWD 183.39M in debt, giving a net cash position of TWD 236.48M billion.
- Cash & Marketable Securities
- TWD 419.87M
- Total Debt
- TWD 183.39M
- Net Cash
- TWD 236.48M
- Net Cash Per Share
- TWD 5.64
- Tangible Book Value Per Share
- TWD 13.38
Margins
Gross margin is 11.75%, with operating margin of -0.39%, and net profit margin of -0.26%.
- Gross Margin
- 11.75%
- Operating Margin
- -0.39%
- Pretax Margin
- -0.29%
- Net Profit Margin
- -0.26%
- EBITDA Margin
- 1.11%
- EBIT Margin
- -0.39%
Analyst Forecast
The average price target for Mytrex Health Technologies, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 7.43%
- EPS Growth Forecast
- 93.62%
